Thromboelastography in veterinary medicine

Bo Wiinberg; Annemarie Thuri Kristensen

doi:10.1055/s-0030-1265291

Thromboelastography in veterinary medicine

51 Citations (Scopus)

Abstract

Thromboelastography (TEG) has been used in experimental animal studies since the early 1960s and in a routine clinical setting for the past decade. From the data currently available, it is clear that both the scope and limitations of TEG in animals resemble those observed in humans. TEG has been used to diagnose hypercoagulability in animals with disseminated intravascular coagulation, various types of cancer, and critical illness. Its ability to detect and monitor animals with various types of coagulopathies has been well established, both clinically and in experimental studies. TEG is often used in animals to monitor the effect of different pro- and anticoagulant drugs and often performs better at this task than conventional coagulation assays. TEG is already well established in veterinary medicine, and with the rapid dissemination of the technique currently taking place, we can expect to see a wide variety of interesting animal data published in the near future.

Original language	English
Journal	Seminars in Thrombosis and Hemostasis
Volume	36
Issue number	7
Pages (from-to)	747-756
Number of pages	10
ISSN	0094-6176
DOIs	https://doi.org/10.1055/s-0030-1265291
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1055/s-0030-1265291

HV-referencegruppen. (External organisation)
Annemarie Thuri Kristensen (Member)
1 May 2005 → 30 Apr 2006
Activity: Membership types › Membership in board of company or public organisation

Cite this

@article{f63475648d274f7d8a7b4fc2062e48d9,

title = "Thromboelastography in veterinary medicine",

abstract = "Thromboelastography (TEG) has been used in experimental animal studies since the early 1960s and in a routine clinical setting for the past decade. From the data currently available, it is clear that both the scope and limitations of TEG in animals resemble those observed in humans. TEG has been used to diagnose hypercoagulability in animals with disseminated intravascular coagulation, various types of cancer, and critical illness. Its ability to detect and monitor animals with various types of coagulopathies has been well established, both clinically and in experimental studies. TEG is often used in animals to monitor the effect of different pro- and anticoagulant drugs and often performs better at this task than conventional coagulation assays. TEG is already well established in veterinary medicine, and with the rapid dissemination of the technique currently taking place, we can expect to see a wide variety of interesting animal data published in the near future.",

author = "Bo Wiinberg and Kristensen, {Annemarie Thuri}",

year = "2010",

doi = "10.1055/s-0030-1265291",

language = "English",

volume = "36",

pages = "747--756",

journal = "Seminars in Thrombosis and Hemostasis",

issn = "0094-6176",

publisher = "Thieme Medical Publishers, Inc.",

number = "7",

}

TY - JOUR

T1 - Thromboelastography in veterinary medicine

AU - Wiinberg, Bo

AU - Kristensen, Annemarie Thuri

PY - 2010

Y1 - 2010

N2 - Thromboelastography (TEG) has been used in experimental animal studies since the early 1960s and in a routine clinical setting for the past decade. From the data currently available, it is clear that both the scope and limitations of TEG in animals resemble those observed in humans. TEG has been used to diagnose hypercoagulability in animals with disseminated intravascular coagulation, various types of cancer, and critical illness. Its ability to detect and monitor animals with various types of coagulopathies has been well established, both clinically and in experimental studies. TEG is often used in animals to monitor the effect of different pro- and anticoagulant drugs and often performs better at this task than conventional coagulation assays. TEG is already well established in veterinary medicine, and with the rapid dissemination of the technique currently taking place, we can expect to see a wide variety of interesting animal data published in the near future.

AB - Thromboelastography (TEG) has been used in experimental animal studies since the early 1960s and in a routine clinical setting for the past decade. From the data currently available, it is clear that both the scope and limitations of TEG in animals resemble those observed in humans. TEG has been used to diagnose hypercoagulability in animals with disseminated intravascular coagulation, various types of cancer, and critical illness. Its ability to detect and monitor animals with various types of coagulopathies has been well established, both clinically and in experimental studies. TEG is often used in animals to monitor the effect of different pro- and anticoagulant drugs and often performs better at this task than conventional coagulation assays. TEG is already well established in veterinary medicine, and with the rapid dissemination of the technique currently taking place, we can expect to see a wide variety of interesting animal data published in the near future.

U2 - 10.1055/s-0030-1265291

DO - 10.1055/s-0030-1265291

M3 - Journal article

C2 - 20978995

SN - 0094-6176

VL - 36

SP - 747

EP - 756

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

IS - 7

ER -

Thromboelastography in veterinary medicine

Abstract

UN SDGs

Access to Document

Fingerprint

Activities

HV-referencegruppen. (External organisation)

Cite this